EUVIMEDEUVIMED entdecken
Crossref

Enteral metallic stenting in malignant gastric outlet obstruction: a prospective data analysis and long-term follow-up

M. Amata, D. Scimeca, C. Ciccioli, F. Mocciaro, A. Bonaccorso, B. Scrivo, E. Conte, A. Calì, V. Di Martino, S. Sferrazza, R. Di Mitri

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S437

DOI: 10.1055/s-0044-1783797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von M. Amata und 10 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The aim of the study was to confirm the long-term efficacy and safety of duodenal uncovered self-expandable metallic stent (SEMS) in malignant gastric outlet obstruction (GOO).

Methods

This is a retrospective single-centre study with a prospective follow-up and data collection that was performed in a tertiary-care referral centre for biliopancreatic diseases in Sicily. We retrospective enrolled all the patients with GOO treated with SEMS from April 2018 till April 2023 with a minimum prospective follow-up of 6-months. We excluded from the data analysis the group of patients that did not follow our prospective scheduled interviews every 3-6 months by hospital consults or calls. Technical success (TS) was defined as correct placement of the fully opened SEMS across the stricture, confirmed fluoroscopically. Clinical success was identified as improvement of GOO Scoring System (GOOSS) at 1 month.

Results

106 patients (49 male, 57 female; median age 70,85±12,4 years) were enrolled. 23 had advanced neoplasia with peritoneal carcinosis or metastasis at baseline. 66 patients required also an EUS-guided biliary drainage with Lumen Apposing Metal Stent (LAMS) in the same or delayed session. The malignant stenosis was classified according to Mutignani’s classification [ 1 ]: type I (54%\59 patients), type II (18.5%\21 patients), type I-II (1.5%\3 patients), type III (9%\10 patients), gastric antrum (17%\19 patients). SEMS’s length was 9cmx22mm (50 cases), 6cmx22mm (49 cases), 12cmx22mm (7 cases). Technical success was 100% and procedural time was 14±7,08 minutes. For the prospective follow-up, 44 patients were lost at the follow-up and so excluded. Data analysis was executed in the remained 60 patients: 21 presented advanced malignant neoplasia with carcinomatosis and metastasis reporting SEMS’s clinical failure and premature death within 30-days. The remained 39 cases reported a long period of indwelling stent without symptoms (mean 176,6±176,02 [30-730] days). The GOOSS significantly increased before and after SEMS placement (0.05 vs. 2.56). A solid/soft solids diet was reported in 32 patients and liquid/soft solids in 7 cases during the prospective period. Mean follow-up was 239±249,49 (30-1090) days. 12 patients developed obstructive symptoms due to SEMS ingrowth that was treated with stent-in-stent tecnique and two cases required a EUS-guided gastro-enteroanastomosis (EUS-GEA) with LAMS due to a partial open of SEMS's distal flange, with complete TS but requiring prolonged procedural time (104 and 107 minutes, respectively). 7 cases were suitable for surgical treatment and the remained group died for biliopancreatic malignancy.

Conclusions

Enteral stenting improves quality of life with long-term outcomes, high CS and low adverse events especially in patients candidates to chemotherapy and\or surgery. The tecnique is feasible and safe with excellent rates of TS and fast procedural time, diversely to EUS-GEA. SEMS’s indwelling without occlusion symptoms and the protracted improvement of GOOSS are the main results of our prospective series with a long follow-up. In patients with limited life expectancy, SEMS remains a solution but with low CS due to advanced neoplastic status. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Amata, M., Scimeca, D., Ciccioli, C., Mocciaro, F., Bonaccorso, A., Scrivo, B., Conte, E., Calì, A., Martino, V. D., Sferrazza, S., & Mitri, R. D. (2024). Enteral metallic stenting in malignant gastric outlet obstruction: a prospective data analysis and long-term follow-up. Endoscopy, 56(S 02 S 02), S437. https://doi.org/10.1055/s-0044-1783797

Vancouver

Amata M, Scimeca D, Ciccioli C, Mocciaro F, Bonaccorso A, Scrivo B, et al. Enteral metallic stenting in malignant gastric outlet obstruction: a prospective data analysis and long-term follow-up. Endoscopy. 2024;56(S 02 S 02):S437. doi:10.1055/s-0044-1783797

BibTeX
@article{Amata2024,
  author = {Amata, M. and Scimeca, D. and Ciccioli, C. and Mocciaro, F. and Bonaccorso, A. and Scrivo, B. and Conte, E. and Calì, A. and Martino, V. Di and Sferrazza, S. and Mitri, R. Di},
  title = {Enteral metallic stenting in malignant gastric outlet obstruction: a prospective data analysis and long-term follow-up},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S437},
  doi = {10.1055/s-0044-1783797}
}
Kostenlos starten →